Prognostic validation and clinical implications of the EANO ESMO classification of leptomeningeal metastasis from solid tumors.
Emilie Le RhunPatrick DevosJohannes WellerKatharina SeystahlFrancesca MoAnnette CompterAnna S BerghoffJoost L M JongenFabian WolpertRoberta RudàDieta BrandsmaMartin van den BentMatthias PreusserUlrich HerrlingerMichael WellerPublished in: Neuro-oncology (2021)
The EANO ESMO LM subtypes are highly prognostic and should be considered for stratification and overall design of clinical trials.